What is the main difference between compounded vs brand GLP-1 medications?

Brand and compounded GLP-1 medications differ in how they are made and reviewed. Wegovy and Zepbound are FDA-approved prescription products. Their approval covers specific uses, doses, and product forms. Their manufacturers must follow FDA manufacturing rules. Zepbound acts on both GIP and GLP-1 receptors, though it is often grouped with GLP-1 medicines.

Compounded medications are prepared by a licensed pharmacy for one patient and are not FDA-approved. The FDA does not review each compounded product for safety, effectiveness, or quality before it is provided to a patient. A compounded product should not be assumed to work like a brand product. Results vary.

Compounding may address a medical need that an available approved product cannot meet. It is not simply another approved brand choice. Legal limits also affect when a pharmacy may prepare these medications.

At Verra, a licensed physician in your state reviews your health history and decides whether treatment is appropriate. Ask why a compounded option is being considered and whether an FDA-approved medicine could meet your needs.